Open Access

Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity

  • Michiel M Winter1,
  • Flip JP Bernink1,
  • Maarten Groenink1, 2,
  • Berto J Bouma1,
  • Arie PJ van Dijk3,
  • Willem A Helbing4,
  • Jan GP Tijssen1 and
  • Barbara JM Mulder1, 5Email author
Journal of Cardiovascular Magnetic Resonance200810:40

https://doi.org/10.1186/1532-429X-10-40

Received: 13 June 2008

Accepted: 19 August 2008

Published: 19 August 2008

Abstract

Background

The method used to delineate the boundary of the right ventricle (RV), relative to the trabeculations and papillary muscles in cardiovascular magnetic resonance (CMR) ventricular volume analysis, may matter more when these structures are hypertrophied than in individuals with normal cardiovascular anatomy. This study aimed to compare two methods of cavity delineation in patients with systemic RV.

Methods

Twenty-nine patients (mean age 34.7 ± 12.4 years) with a systemic RV (12 with congenitally corrected transposition of the great arteries (ccTGA) and 17 with atrially switched (TGA) underwent CMR. We compared measurements of systemic RV volumes and function using two analysis protocols. The RV trabeculations and papillary muscles were either included in the calculated blood volume, the boundary drawn immediately within the apparently compacted myocardial layer, or they were manually outlined and excluded. RV stroke volume (SV) calculated using each method was compared with corresponding left ventricular (LV) SV. Additionally, we compared the differences in analysis time, and in intra- and inter-observer variability between the two methods. Paired samples t-test was used to test for differences in volumes, function and analysis time between the two methods. Differences in intra- and inter-observer reproducibility were tested using an extension of the Bland-Altman method.

Results

The inclusion of trabeculations and papillary muscles in the ventricular volume resulted in higher values for systemic RV end diastolic volume (mean difference 28.7 ± 10.6 ml, p < 0.001) and for end systolic volume (mean difference 31.0 ± 11.5 ml, p < 0.001). Values for ejection fraction were significantly lower (mean difference -7.4 ± 3.9%, p < 0.001) if structures were included. LV SV did not differ significantly from RV SV for both analysis methods (p = NS). Including structures resulted in shorter analysis time (p < 0.001), and showed better inter-observer reproducibility for ejection fraction (p < 0.01).

Conclusion

The choice of method for systemic RV cavity delineation significantly affected volume measurements, given the CMR acquisition and analysis systems used. We recommend delineation outside the trabeculations for routine clinical measurements of systemic RV volumes as this approach took less time and gave more reproducible measurements.

Background

The number of adult patients with a congenital heart defect is steadily increasing with the constant improvement of cardiac surgery. A substantial portion of these patients has a morphologic right ventricle (RV) supporting the systemic circulation (e.g. patients with a congenitally corrected transposition of the great arteries (ccTGA) or a complete transposition of the great arteries (TGA) after an atrial switch operation). Medium term survival in patients with a systemic RV is relatively good. However, long-term outcome is unknown, and morbidity is worrisome, with RV dysfunction, tricuspid valve regurgitation, and arrhythmias being the main constituents. [14]

Assessment of ventricular function is of particular importance, as European guidelines consider it an important part of preoperative assessment, (peri-operative) management and follow-up of patients with any congenital heart defect. [5] Moreover, decisions on the timing of surgical intervention in patients with a systemic RV are frequently based on RV function. [6, 7] Therefore, the importance of having an accurate and reproducible diagnostic tool for the evaluation and follow-up of systemic RV volumes and function is evident.

For the assessment of subpulmonary and systemic RV volumes and function Cardiovascular Magnetic Resonance (CMR) is considered the gold standard. [815] In individuals with normal cardiac anatomy the influence of trabeculations and papillary muscles on measured ventricular volumes seems of marginal importance. The differences in measured ventricular volumes and function when these structures are included in the ventricular cavity, compared to when structures are excluded, are small and unlikely to influence clinical decision making.[16, 17] However, patients with a systemic RV pose a challenge, as the method of delineating the cavity relative to the hypertrophied trabeculations and papillary muscles could affect RV volume and function measurements. [18]

To our knowledge, no study has ever addressed the issue of CMR analysis methods in this patient group. Aim of the present study was to evaluate the impact of trabeculations and papillary muscles on systemic RV measurements, by comparing a CMR analysis method in which trabeculations and papillary muscles were included in the RV volume to an analysis method in which these structures were excluded from RV volume (figure 1). Additionally, differences in analysis time and intra- and inter-observer reproducibility between analysis methods were evaluated.
Figure 1

Four chamber image from a multi-phase steady-state free precision sequence of the highly trabeculized systemic RV in a patient with an atrially switched TGA (a) and in a patient with a congenitally corrected TGA (b).

Methods

Study population

A total of 29 adult patients (69% male, mean age 34.7 ± 12.4 years) with a systemic RV underwent CMR for the evaluation of RV volumes and function. Twelve patients had a ccTGA, 17 patients an atrially switched TGA. The Institutional Review Boards of all three participating tertiary referral centers approved the study protocol. Written informed consent was obtained from all patients prior to participation in the study.

Image acquisition

Image acquisition was performed by CMR, using a 1,5 Tesla scanner (Siemens Avanto, Erlangen, Germany), using standardly available sequences to assess ventricular volumes. After visualizing the long and short axes of the heart, a multi-phase steady-state free precession sequence (SSFP) with retrospective electrocardiographic triggering was applied to visualize two-chamber, three-chamber and four-chamber views. Guided by these views, a multislice and multiphase SSFP sequence was applied perpendicular to the ventricular septum, encompassing the total heart. These sequences were individually adjusted to acquire short axis slices with optimal spatial and temporal resolution. Typical parameters were: flip angle: 50–70 degrees; repetition time: 3–4 msec; echo time: 1–2 msec; temporal resolution: 40 msec, 1–2 × 1–2 mm/pixel in-plane spatial resolution, 8 mm slice thickness, and 1 mm interslice gap. This resulted in 9 to 15 slices to cover the whole heart. CMR images were acquired during repeated end-expiratory breath holds.

Image analyses

For CMR image analysis two independent observers (MW, FB) used MASS Analytical Software System (Medis, Leiden, the Netherlands). Cine loops were used to choose end diastole (ED) and end systole (ES). ED was defined as the phase with the largest RV (and left ventricular (LV)) area and ES as the phase with the smallest RV (and LV) area. The slices at the base of the heart were considered to be in the ventricle if the blood was at least half surrounded by ventricular myocardium. Cine loop movies in phase and slice were used in case the distinction between the ventricles, atria and great vessels was unclear. Moreover, four-chamber views in phase with the short axis views were available. Tracing was performed manually on each ED and ES short-axis view.

The sums of the traced contours in ED en ES were used to calculate ED volume (EDV) and ES volume (ESV) using a disc summation technique. EDV and ESV were used to calculate Stroke Volume (SV) and Ejection Fraction (EF). SV was defined as EDV - ESV, and EF as [(EDV - ESV)/EDV] × 100%.

CMR analysis methods

All contours were traced twice, using two different tracing methods. Both the systemic RV, and the subpulmonary LV were subjected to both analysis methods. Method A: Contour tracing was first performed including the papillary muscles and trabeculations in the ventricular cavity, by tracing immediately within the apparently compact layer of the myocardium. A continuous movie display of the slice being evaluated was used to enhance differentiation between trabeculations, papillary muscles and the ventricular free wall. Although the exclusion of complex RV trabeculations and papillary muscles is relatively easy in ED, optimal differentiation is especially important in the ES phases as trabeculations and papillary muscles compress and fold during systole making the end-systolc border of trabeculations and blood volume less distinct. This method resulted in smooth contours (figure 2, method A). Method B: Contour tracing was then performed excluding the papillary muscles and trabeculations from the ventricular volume. This was done by tracing around these structures if attached to the ventricular wall and by tracing them separately if not attached to the ventricular wall. This resulted in irregular endocardial contours (figure 2, method B).
Figure 2

Assessment of systemic right ventricular volumes using two different analysis protocols. Short axis view from a multi-phase steady-state free precision sequence in end systole (left) and end diastole (right) obtained in a patient with an atrially switched TGA demonstrating the two analysis protocols. Method A depicts the inclusion of trabeculations and papillary muscles in the ventricular cavity. Method B depicts the exclusion of trabeculations and papillary muscles from the ventricular cavity. LV = left ventricle.

To ensure that found differences would only be due to the impact of papillary muscles and trabeculations both analysis methods were performed on the same ED and ES phases, and the same slices for each patient. Duration of RV volume and function analysis was recorded for both analysis methods.

Statistical methods

For statistical analyses SPSS 12.0.1 (SPSS Inc., Chicago, Illinois) for Windows was used. P values < 0.05 were considered statistically significant. The shift between the two tracing methods was compared with the two-tailed paired t test, calculating mean, standard deviation and statistical significance of the differences. The agreement between the two tracing methods was assessed and visualized with the method and plots as described by Bland and Altman. [19] Agreement between RV SV and LV SV for both analysis methods was assessed using a two-tailed paired t test.

Intra- and inter-observer reproducibility of the two analysis methods was determined from the mean value and the differences between the two measurements. The coefficient of variability was calculated as the standard deviation of the difference of the paired measurements divided by the mean of the average of the paired measurements, and expressed as a percentage. An extension of the Bland-Altman method was used to assess the statistical significance of differences in intra- and interobserver reproducibility between the two analysis methods. A log transformation of the squared differences between the two measurements was performed. If the squared difference was zero, we replaced the value by the next smallest value multiplied by 0.5. A two-tailed paired t test of the logged squared differences was performed thereafter.[16]

Results

Differences in measured volumes and function (Additional file 1)

Including trabeculations and papillary muscles in the systemic RV volume (Method A) resulted in significantly higher outcome measures for EDV with a mean difference of 28.7 ml (95% CI 24.7 – 32.7, p < 0.001), and for ESV with a mean difference of 31.0 ml (95% CI 26.7 – 35.4, p < 0.001), compared to when structures were excluded from the ventricular volume (Method B). This resulted in a significantly lower calculated systemic RV EF with a mean difference of 7.4% (95% CI -8.9 – -5.9, p < 0.001). No significant changes were found for SV and CO. Bland-Altman plots were used to visualize the systematic differences between Method A and B (figure 3).
Figure 3

Bland-Altman plots demonstrating the systematic differences in measured systemic right ventricular volumes and function between Method A and Method B. Bland-Altman plots demonstrate on the X-axis the mean value of Method A and Method B for each parameter (a. mean end diastolic volume; b. mean end systolic volume; c. mean stroke volume; d. mean ejection fraction), and on the Y-axis the difference between the two analysis methods for the same parameter. The solid line represents the mean value of the difference for each method, the dotted lines represent ± 2 SD. RVEDV = right ventricular end diastolic volume; RVEF = right ventricular ejection fraction; RVESV = right ventricular end systolic volume; ml = millilitre; SD = standard deviation; RVSV = right ventricular stroke volume. The 'A' or 'B' behind parameters indicate that values were obtained using Method A or Method B respectively.

We found no statistically significant differences between RV SV and LV SV, when trabeculations and papillary muscles were included in the RV and LV volumes (75.5 ± 18.5 ml vs. 71.1 ± 23.9 ml; p = NS), neither when structures were excluded from the RV and LV volumes (77.8 ± 18.4 ml vs. 69.3 ± 22.3 ml, p = NS).

Analysis time was significantly shorter when using Method A (20 ± 3 min) compared to Method B (26 ± 4 min); p < 0.001.

Observer reproducibility

Analysis Method A lead to a lower coefficient of variability for all outcome measures compared to Method B. This indicates superior intra- and inter-observer reproducibility when including trabeculations and papillary muscles in the ventricular volume compared to excluding these structures. Although these differences were not found to be statistically significant for the intra-observer measurements, we found statistically significant difference in the inter-observer reproducibility of systemic RV SV (p < 0.05) and EF (P < 0.01), favoring the inclusion of structures in the ventricular volume (Additional file 2).

Discussion

Including trabeculations and papillary muscles in the systemic RV cavity lead to a substantially higher measured EDV and ESV and a substantially lower calculated EF, compared to excluding these structures from the volume of the cavity. Although the influence of these structures on measured ventricular volumes in individuals with normal cardiac anatomy seems of marginal clinical importance,[16, 17] their influence on systemic RV volumes was found to be striking. Moreover, there were statistically significant differences in analysis time and in reproducibility between CMR analysis methods.

Although CMR is considered the most accurate diagnostic tool for the assessment of ventricular volumes and function, [1113, 20, 21], there is no consensus in the literature on the role of trabeculations and papillary muscles. In anatomically normal hearts, Lorenz et al. excluded trabeculations and papillary muscles from the LV and the RV cavity,[12] whereas Rominger et al. chose to include these structures.[13] Most authors, however, refrained from specifying the role of trabeculations and/or papillary muscles in their analysis method. [2225] Similar incompleteness in methodology of CMR analysis is seen in literature regarding patients with congenital heart defects, and with systemic RVs in specific. Although Helbing et al. excluded papillary muscles and the moderator band from the RV cavity of patients with congenital heart defects,[10] and Lidegram et al. chose to include both structures in the cavity of the systemic RV,[26] most authors are less specific on the role of these structures in their analysis method.[11, 21, 27]

The influence of trabeculations and papillary muscles on LV and RV measurements in healthy subjects and patients with known cardiac disease (patients with congenital heart defects were excluded) has been studied previously, using similar analysis protocols as were used in our study.[16, 17] In anatomically normal hearts, both Sievers et al. and Papavassiliu et al. found significant differences in measured left and right ventricular volumes and function when comparing both CMR analysis protocols. However, both authors concluded that the observed differences in ventricular volumes and function were too small to influence clinical decision making, and advised the inclusion of all structures in the ventricular cavity. Including structures not only shortened analysis time, Papavassiliu et al. also demonstrated superior reproducibility for several outcome measures when using this analysis protocol.[16, 17] Our observations in systemic RVs differ from those of Sievers and Papavassiliu, as we found systematic and large differences in measured systemic RV volumes and function between the two analysis methods. This study indicates the importance of a consistent approach to cavity delineation relative to the trabeculations and papillary muscles, to avoid misinterpretation of measurements and erroneous clinical decision making.[5, 6]

Although the true values of systemic RV volumes and function remain unknown, and in spite of tricuspid valve regurgitation in some patients, we found no significant differences between the measured RV and LV SV by either method of analysis. However, delineation of the RV cavity boundary outside the trabeculations and papillary muscles had the advantages of shorter analysis time and better inter-observer reproducibility. We therefore recommend the use of this approach in routine CMR measurements of systemic RV volumes, at least when comparable systems for CMR acquisition and volume analysis are being used.

Study limitations

The sample size of 29 patients in two distinct clinical categories is relatively small. The methods used were not suitable for determining which of the analysis approaches measured systemic RV volumes more accurately. Measurements of systemic RV mass were not attempted, and remain challenging given the relative amount of trabeculated RV myocardium. The slice thickness of 8 mm may not have been optimal for clear delineation of the trabeculations, making the definition of the boundaries between trabeculations and blood, and between trabeculations and apparently compact myocardium hard to define in some cases. Moreover, as myocardial boundaries were first defined at end diastole, detecting the corresponding boundary at end systole could be difficult, due to elimination of blood from the inter-trabecular spaces at end systole. The important issue of inter-study reproducibility was not addressed by this study. Between studies, volume measurements might be affected by variation in the relative positioning of the basal short axis slice, and by variables such as the shimming of the magnet and the reliability of ECG triggering.

Conclusion

We found the method of systemic RV cavity delineation to affect the measurements of cavity volume, given the CMR acquisition and analysis systems used. We recommend cavity delineation inside the apparently compact myocardium of the RV but outside the trabeculations and papillary muscles for routine clinical measurements of systemic RV volumes as this approach took less time and gave more reproducible values.

Abbreviations

ccTGA: 

congenitally corrected transposition of the great arteries

CHD: 

congenital heart defect

CMR: 

cardiovascular magnetic resonance

CO: 

cardiac output

EDV: 

end diastolic volume

EF: 

ejection fraction

ESV: 

end systolic volume

LV: 

left ventricle

RV: 

right ventricle

SV: 

stroke volume

TGA: 

transposition of the great arteries

Declarations

Authors’ Affiliations

(1)
Department of Cardiology, Academic Medical Center
(2)
Department of Radiology, Academic Medical Center
(3)
Department of Cardiology, University Medical Center Nijmegen
(4)
Department of Cardiology, Erasmus MC – Sophia Children's Hospital
(5)
Department of Cardiology, University Medical Center Utrecht

References

  1. Budts W, Scheurwegs C, Stevens A, Moons P, Van DK, Vanhees L: The future of adult patients after Mustard or Senning repair for transposition of the great arteries. Int J Cardiol. 2006, 113: 209-214. 10.1016/j.ijcard.2005.11.015.View ArticlePubMedGoogle Scholar
  2. Rutledge JM, Nihill MR, Fraser CD, Smith OE, McMahon CJ, Bezold LI: Outcome of 121 patients with congenitally corrected transposition of the great arteries. Pediatr Cardiol. 2002, 23: 137-145. 10.1007/s00246-001-0037-8.View ArticlePubMedGoogle Scholar
  3. Tulevski II, Dodge-Khatami A, Groenink M, Van der Wall EE, Romkes H, Mulder BJ: Right ventricular function in congenital cardiac disease: noninvasive quantitative parameters for clinical follow-up. Cardiol Young. 2003, 13: 397-403.PubMedGoogle Scholar
  4. Warnes CA: Transposition of the great arteries. Circulation. 2006, 114: 2699-2709. 10.1161/CIRCULATIONAHA.105.592352.View ArticlePubMedGoogle Scholar
  5. Deanfield J, Thaulow E, Warnes C, Webb G, Kolbel F, Hoffman A, Sorenson K, Kaemmer H, Thilen U, Bink-Boelkens M, Iserin L, Daliento L, Silove E, Redington A, Vouhe P, Priori S, Alonso MA, Blanc JJ, Budaj A, Cowie M, Deckers J, Fernandez BE, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth O, Trappe HJ, Klein W, Blomstrom-Lundqvist C, de BG, Hradec J, Mazzotta G, Parkhomenko A, Presbitero P, Torbicki A: Management of grown up congenital heart disease. Eur Heart J. 2003, 24: 1035-1084. 10.1016/S0195-668X(03)00131-3.View ArticlePubMedGoogle Scholar
  6. van Son JA, Danielson GK, Huhta JC, Warnes CA, Edwards WD, Schaff HV, Puga FJ, Ilstrup DM: Late results of systemic atrioventricular valve replacement in corrected transposition. J Thorac Cardiovasc Surg. 1995, 109: 642-652. 10.1016/S0022-5223(95)70345-4.View ArticlePubMedGoogle Scholar
  7. Voskuil M, Hazekamp MG, Kroft LJ, Lubbers WJ, Ottenkamp J, Van der Wall EE, Zwinderman KH, Mulder BJ: Postsurgical course of patients with congenitally corrected transposition of the great arteries. Am J Cardiol. 1999, 83: 558-562. 10.1016/S0002-9149(98)00913-8.View ArticlePubMedGoogle Scholar
  8. Dodge-Khatami A, Tulevski II, Bennink GB, Hitchcock JF, de Mol BA, Van der Wall EE, Mulder BJ: Comparable systemic ventricular function in healthy adults and patients with unoperated congenitally corrected transposition using MRI dobutamine stress testing. Ann Thorac Surg. 2002, 73: 1759-1764. 10.1016/S0003-4975(02)03553-1.View ArticlePubMedGoogle Scholar
  9. Groenink M, Mulder BJ, Van der Wall EE: Value of magnetic resonance imaging in functional assessment of baffle obstruction after the Mustard procedure. J Cardiovasc Magn Reson. 1999, 1: 49-51. 10.3109/10976649909080833.View ArticlePubMedGoogle Scholar
  10. Helbing WA, Rebergen SA, Maliepaard C, Hansen B, Ottenkamp J, Reiber JH, De RA: Quantification of right ventricular function with magnetic resonance imaging in children with normal hearts and with congenital heart disease. Am Heart J. 1995, 130: 828-837. 10.1016/0002-8703(95)90084-5.View ArticlePubMedGoogle Scholar
  11. Lorenz CH, Walker ES, Graham TP, Powers TA: Right ventricular performance and mass by use of cine MRI late after atrial repair of transposition of the great arteries. Circulation. 1995, 92: II233-II239.View ArticlePubMedGoogle Scholar
  12. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP: Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson. 1999, 1: 7-21. 10.3109/10976649909080829.View ArticlePubMedGoogle Scholar
  13. Rominger MB, Bachmann GF, Pabst W, Rau WS: Right ventricular volumes and ejection fraction with fast cine MR imaging in breath-hold technique: applicability, normal values from 52 volunteers, and evaluation of 325 adult cardiac patients. J Magn Reson Imaging. 1999, 10: 908-918. 10.1002/(SICI)1522-2586(199912)10:6<908::AID-JMRI2>3.0.CO;2-2.View ArticlePubMedGoogle Scholar
  14. Sechtem U, Pflugfelder PW, Gould RG, Cassidy MM, Higgins CB: Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology. 1987, 163: 697-702.View ArticlePubMedGoogle Scholar
  15. Tulevski II, Van der Wall EE, Groenink M, Dodge-Khatami A, Hirsch A, Stoker J, Mulder BJ: Usefulness of magnetic resonance imaging dobutamine stress in asymptomatic and minimally symptomatic patients with decreased cardiac reserve from congenital heart disease (complete and corrected transposition of the great arteries and subpulmonic obstruction). Am J Cardiol. 2002, 89: 1077-1081. 10.1016/S0002-9149(02)02279-8.View ArticlePubMedGoogle Scholar
  16. Papavassiliu T, Kuhl HP, Schroder M, Suselbeck T, Bondarenko O, Bohm CK, Beek A, Hofman MM, van Rossum AC: Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging. Radiology. 2005, 236: 57-64. 10.1148/radiol.2353040601.View ArticlePubMedGoogle Scholar
  17. Sievers B, Kirchberg S, Bakan A, Franken U, Trappe HJ: Impact of papillary muscles in ventricular volume and ejection fraction assessment by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2004, 6: 9-16. 10.1081/JCMR-120027800.View ArticlePubMedGoogle Scholar
  18. Tulevski II, Romkes H, Dodge-Khatami A, Van der Wall EE, Groenink M, van Veldhuisen DJ, Mulder BJ: Quantitative assessment of the pressure and volume overloaded right ventricle: imaging is a real challenge. Int J Cardiovasc Imaging. 2002, 18: 41-51. 10.1023/A:1014315329767.View ArticlePubMedGoogle Scholar
  19. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.View ArticlePubMedGoogle Scholar
  20. Oosterhof T, Tulevski II, Vliegen HW, Spijkerboer AM, Mulder BJ: Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol. 2006, 97: 1051-1055. 10.1016/j.amjcard.2005.10.047.View ArticlePubMedGoogle Scholar
  21. Pattynama PM, Lamb HJ, Van der Velde EA, Van der Geest RJ, Van der Wall EE, De RA: Reproducibility of MRI-derived measurements of right ventricular volumes and myocardial mass. Magn Reson Imaging. 1995, 13: 53-63. 10.1016/0730-725X(94)00076-F.View ArticlePubMedGoogle Scholar
  22. Alfakih K, Reid S, Jones T, Sivananthan M: Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol. 2004, 14: 1813-1822. 10.1007/s00330-004-2387-0.View ArticlePubMedGoogle Scholar
  23. Beygui F, Furber A, Delepine S, Helft G, Metzger JP, Geslin P, Le Jeune JJ: Routine breath-hold gradient echo MRI-derived right ventricular mass, volumes and function: accuracy, reproducibility and coherence study. Int J Cardiovasc Imaging. 2004, 20: 509-516. 10.1007/s10554-004-1097-7.View ArticlePubMedGoogle Scholar
  24. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ: Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004, 147: 218-223. 10.1016/j.ahj.2003.10.005.View ArticlePubMedGoogle Scholar
  25. Tandri H, Daya SK, Nasir K, Bomma C, Lima JA, Calkins H, Bluemke DA: Normal reference values for the adult right ventricle by magnetic resonance imaging. Am J Cardiol. 2006, 98: 1660-1664. 10.1016/j.amjcard.2006.07.049.View ArticlePubMedGoogle Scholar
  26. Lidegran M, Odhner L, Jacobsson LA, Greitz D, Lundell B: Magnetic resonance imaging and echocardiography in assessment of ventricular function in atrially corrected transposition of the great arteries. Scand Cardiovasc J. 2000, 34: 384-389. 10.1080/14017430050196207.View ArticlePubMedGoogle Scholar
  27. Lissin LW, Li W, Murphy DJ, Hornung T, Swan L, Mullen M, Kilner P, Gatzoulis MA: Comparison of transthoracic echocardiography versus cardiovascular magnetic resonance imaging for the assessment of ventricular function in adults after atrial switch procedures for complete transposition of the great arteries. Am J Cardiol. 2004, 93: 654-657. 10.1016/j.amjcard.2003.11.044.View ArticlePubMedGoogle Scholar

Copyright

© Winter et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.